Nine new medication have come substantially closer to a European launch during June after the Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation of the treatments.
These medications are now on the verge gaining a European marketing permit being that CHMP’s recommendations are customarily followed by the EU Commission, the formal authorizing institution.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Demant rejects criticisms of lobbying efforts against OTC channel: "That’s how America works"
To ensure users receive a high-quality device, CEO Søren Nielsen says Demant has lobbied the FDA through a US-based industry association as it attempts to established the rules for the upcoming over-the-counter hearing aids sales channel.
Sonova downgrades, blames high costs and weak results from key markets
The hearing aid giant now expects revenue growth of 15-19% measured in local currencies, compared to a previous 17-21%.
Demant CEO highlights strong performance from Diagnostics, acknowledges Communications letdown
The Danish hearing aid manufacturer’s diagnostics business area is a beacon of light among gloomy H1 financial figures, mostly coming from headset firm Epos, says CEO Søren Nielsen.
Analyst to hone in on Vyepti rollout and patient uptake in imminent Lundbeck report
The preventive migraine treatment, Vyepti, will likely be a key element of the Danish pharmaceutical firm’s upcoming second quarterly report on Wednesday.
US downswing reflects shift in underlying demand, says Demant CEO
Demand for hearing aids on the US market will return in the future, according to Demant CEO Søren Nielsen, who thinks people are postponing the decision to acquire a device due to the challenging economic environment.
Antibody Engineering Scientist 
Lead Automation Engineer ABB Sattline/ABB 800XA, AFRY 
IT QA Manager 
Senior Manager, QA GCP/PV 
Global Quality Director (Business Unit Quality Lead) 
Head of Regulatory Services Denmark 
Experienced Biostatistician 
Clinical Trial Manager - Black Swans Exist 
Scientist Radiochemistry 
Director Regulatory Affairs 
Key Account Manager 
Vice President/Senior Director of Medicinal Chemistry 
Senior Clinical Trial Manager - Black Swans Exist